• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床质谱方法在多发性骨髓瘤和淀粉样变性中的应用。

Clinical Mass Spectrometry Approaches to Myeloma and Amyloidosis.

机构信息

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

出版信息

Clin Lab Med. 2021 Jun;41(2):203-219. doi: 10.1016/j.cll.2021.03.003. Epub 2021 Apr 24.

DOI:10.1016/j.cll.2021.03.003
PMID:34020760
Abstract

The diagnosis of myeloma and other plasma cell disorders has traditionally been done with the aid of electrophoretic methods, whereas amyloidosis has been characterized by immunohistochemistry. Mass spectrometry has recently been established as an alternative to these traditional methods and has been proved to bring added benefit for patient care. These newer mass spectrometry-based methods highlight some of the key advantages of modern proteomic methods and how they can be applied to the routine care of patients.

摘要

传统上,多发性骨髓瘤和其他浆细胞疾病的诊断是借助电泳方法进行的,而淀粉样变性则通过免疫组织化学进行特征描述。质谱分析最近已被确立为这些传统方法的替代方法,并已被证明可为患者护理带来额外的益处。这些基于质谱的新技术突出了现代蛋白质组学方法的一些关键优势,以及它们如何应用于患者的常规护理。

相似文献

1
Clinical Mass Spectrometry Approaches to Myeloma and Amyloidosis.临床质谱方法在多发性骨髓瘤和淀粉样变性中的应用。
Clin Lab Med. 2021 Jun;41(2):203-219. doi: 10.1016/j.cll.2021.03.003. Epub 2021 Apr 24.
2
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report.质谱法评估多发性骨髓瘤和相关疾病中的单克隆蛋白:国际骨髓瘤工作组质谱学委员会报告。
Blood Cancer J. 2021 Feb 1;11(2):24. doi: 10.1038/s41408-021-00408-4.
3
Improved Screening of Monoclonal Gammopathy Patients by MALDI-TOF Mass Spectrometry.MALDI-TOF 质谱法提高单克隆丙种球蛋白血症患者的筛查率。
J Am Soc Mass Spectrom. 2023 Dec 6;34(12):2646-2653. doi: 10.1021/jasms.3c00166. Epub 2023 Nov 23.
4
Bringing mass spectrometry into the care of patients with multiple myeloma.将质谱分析引入多发性骨髓瘤患者的护理中。
Int J Hematol. 2022 Jun;115(6):790-798. doi: 10.1007/s12185-022-03364-2. Epub 2022 Apr 26.
5
The potential role of mass spectrometry for the identification and monitoring of patients with plasma cell disorders: Where are we now and which questions remain unanswered?质谱分析在浆细胞疾病患者的鉴定和监测中的潜在作用:我们现在在哪里,还有哪些问题没有答案?
Br J Haematol. 2022 Aug;198(4):641-653. doi: 10.1111/bjh.18226. Epub 2022 May 5.
6
Current Status of Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in Clinical Diagnostic Microbiology.基质辅助激光解吸电离飞行时间质谱技术(MALDI-TOF MS)在临床诊断微生物学中的应用现状。
Molecules. 2020 Oct 17;25(20):4775. doi: 10.3390/molecules25204775.
7
Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma.对比基于 MALDI-TOF 质谱分析的外周血和骨髓流式细胞术用于多发性骨髓瘤患者微小残留病灶的检测。
Br J Haematol. 2020 Jun;189(5):904-907. doi: 10.1111/bjh.16443. Epub 2020 Feb 5.
8
Primary amyloidosis (and plasma cell dyscrasia).
Arch Dermatol. 1965 Jul;92(1):108-10. doi: 10.1001/archderm.92.1.108a.
9
Nanoporous silica coupled MALDI-TOF MS detection of Bence-Jones proteins in human urine for diagnosis of multiple myeloma.纳米孔二氧化硅与 MALDI-TOF MS 检测人尿液中的 Bence-Jones 蛋白用于多发性骨髓瘤的诊断。
Talanta. 2019 Aug 1;200:288-292. doi: 10.1016/j.talanta.2019.03.067. Epub 2019 Mar 16.
10
[New Insights into Diagnosis and Pathogenesis of Amyloidosis by Mass Spectrometric Analysis].[通过质谱分析对淀粉样变性病诊断和发病机制的新见解]
Rinsho Byori. 2016 Jun;64(6):675-679.

引用本文的文献

1
Clinical analysis of 37 Chinese patients with ocular amyloidosis: a single center study.37 例中国人眼类淀粉样变性的临床分析:一项单中心研究。
BMC Ophthalmol. 2024 Jul 18;24(1):294. doi: 10.1186/s12886-024-03548-w.
2
M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibrator.采用超灵敏靶向质谱法和即用型校准品对多发性骨髓瘤患者的 M 蛋白进行诊断。
Clin Chem Lab Med. 2023 Oct 12;62(3):540-550. doi: 10.1515/cclm-2023-0781. Print 2024 Feb 26.
3
Diagnosis for Chinese patients with light chain amyloidosis: a scoping review.
中文轻链淀粉样变性患者的诊断:范围综述。
Ann Med. 2023 Dec;55(1):2227425. doi: 10.1080/07853890.2023.2227425.
4
Monoclonal gammopathy of thrombotic/thrombocytopenic significance.具有血栓形成/血小板减少意义的单克隆丙种球蛋白病
Blood. 2023 Apr 6;141(14):1772-1776. doi: 10.1182/blood.2022018797.
5
Retrospective Longitudinal Monitoring of Multiple Myeloma Patients by Mass Spectrometry Using Archived Serum Protein Electrophoresis Gels and De Novo Sequence Analysis.使用存档血清蛋白电泳凝胶和从头测序分析通过质谱对多发性骨髓瘤患者进行回顾性纵向监测。
Hemasphere. 2022 Aug 2;6(8):e758. doi: 10.1097/HS9.0000000000000758. eCollection 2022 Aug.
6
Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT.单克隆和寡克隆抗血小板因子 4 抗体介导 VITT。
Blood. 2022 Jul 7;140(1):73-77. doi: 10.1182/blood.2021014588.
7
Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin.抗PF4 VITT抗体是寡克隆性的,且可被肝素不同程度地抑制。
medRxiv. 2021 Sep 24:2021.09.23.21263047. doi: 10.1101/2021.09.23.21263047.